Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 28921 AL 28935

Association of Cardiovascular-Kidney-Metabolic Syndrome With Cognitive Decline and Dementia: The ARIC Study Insights

Xie P, Wang Y, Xu X, Tan L, Guo X, Xu Z, Ye R, Zhang M, Zhuang X, Li Z, Chen W, Liao X, Li B.

J Am Heart Assoc. 2025 May 20;14(10):e038445. doi: 10.1161/JAHA.124.038445. Epub 2025 May 15.

Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older Adults

Zhou Z, Moran C, Murray AM, Zoungas S, Magnussen C, Chong TT, Shah RC, Sheets KM, Nelson M, Zhu C, Tonkin AM, Talic S, Ernst ME, Orchard SG, McNeil JJ, Wolfe R, Woods RL, Neumann JT, Qiu P, Ryan J.

Neurology. 2025 Feb 25;104(4):e210247. doi: 10.1212/WNL.0000000000210247. Epub 2025 Jan 29.

Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia

Nakamura Y, Adachi J, Hirota N, Iba K, Sasajima C, Shimizu K, Nakai M, Takahashi K.

Alzheimers Dement. 2025 Jul;21(7):e70522. doi: 10.1002/alz.70522.

Reminiscence therapy delivery formats for older adults with dementia or mild cognitive impairment: A systematic review and network meta-analysis

Pu Y, Zhang G, You S, Gains H, Huang K, Jiao Y, He R, Han B, Yang H, Jia Y, Chen L.

Int J Nurs Stud. 2025 Aug;168:105085. doi: 10.1016/j.ijnurstu.2025.105085. Epub 2025 Apr 14.

Donanemab for Alzheimer's disease: from preclinical research to the clinical application

Dodel R, Frölich L.

Expert Rev Neurother. 2025 Oct;25(10):1151-1163. doi: 10.1080/14737175.2025.2546868. Epub 2025 Aug 25.

Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis

Hui EK, Mukadam N, Kohl G, Livingston G.

J Alzheimers Dis. 2025 Apr;104(3):627-648. doi: 10.1177/13872877251319054. Epub 2025 Feb 27.

Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial

Rajji TK, Baksh SN, Shade DM, Ismail Z, Burhan AM, Okhravi HR, Padala PR, Rosenberg PB, Schneider LS, Porsteinsson AP, Lyketsos CG; S-CitAD Research Group.

Nat Med. 2025 May;31(5):1586-1591. doi: 10.1038/s41591-025-03569-y. Epub 2025 Mar 25.

Multisensory stimulation reduces neuropsychiatric symptoms and enhances cognitive function in older adults with dementia: A meta-analysis of randomized controlled trials

Octary T, Fajarini M, Arifin H, Chen R, Sung CM, Chang LF, Wang CH, Banda KJ, Chou KR.

J Prev Alzheimers Dis. 2025 May;12(5):100091. doi: 10.1016/j.tjpad.2025.100091. Epub 2025 Feb 21.

Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis

Arroyo-Pacheco N, Sarmiento-Blanco S, Vergara-Cadavid G, Castro-Leones M, Contreras-Puentes N.

Ageing Res Rev. 2025 Feb;104:102620. doi: 10.1016/j.arr.2024.102620. Epub 2024 Dec 3.

Implementing early detection of cognitive impairment in primary care to improve care for older adults

Fowler NR, Partrick KA, Taylor J, Hornbecker M, Kelleher K, Boustani M, Cummings JL, MacLeod T, Mielke MM, Brosch JR, Lee J, Shobin E, Galvin JE, Fillit H, Udeh-Momoh C, Willis DR.

J Intern Med. 2025 Jul;298(1):31-45. doi: 10.1111/joim.20098. Epub 2025 May 23.

Efficacy of non-invasive brain stimulation interventions on cognitive impairment: an umbrella review of meta-analyses of randomized controlled trials

Wu M, Song W, Wang X, Teng L, Li J, Zhang J, Li X, Yu D, Jia H, Wang B, Tang Q, Zhu L.

J Neuroeng Rehabil. 2025 Feb 5;22(1):22. doi: 10.1186/s12984-025-01566-3.

Canadian Stroke Best Practice Recommendations: Vascular cognitive impairment, 7th edition practice guidelines update, 2024

Swartz RH, Longman RS, Lindsay MP, Lund R, Ganesh A, Eskes GA, Austin M, Bechard LE, Bhangu J, Bruto VC, Carter S, Chow N, Deschaintre Y, Fedorchuk K, Fellows L, Foley N, Greer LA, Lee DS, Leonard C, Patel R, Poonyania S, Poulin V, Quraishi F, Roach P, Shoniker T, Tuchak C, Mountain A, Martin C, Smith EE; Canadian Stroke Best Practice Recommendations Advisory Committee, in collaboration with the Canadian Stroke Consortium, Canadian Neurological Sciences Federation, and CanStroke Recovery Trials Platform.

Alzheimers Dement. 2025 Jan;21(1):e14324. doi: 10.1002/alz.14324. Epub 2025 Jan 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias